Hanmi’s Eppe Undercuts Wegovy and Mounjaro as Korea’s First Homegrown GLP-1 Obesity Drug
Hanmi’s Eppe launched in Korea at 129,800 won for four weeks, undercutting Wegovy and Mounjaro on price but facing unproven comparative efficacy and a possible managed-coverage shift.